Northern Ireland Cancer Trials Network
NICTC has been successful in obtaining a research grant from Cancer Research UK (CR-UK) and the Northern Ireland Health and Social Care Research and Development Division of the Public Health Agency (NI HSC R&DD) to support the formation of the Northern Ireland Cancer Trials Network (NICTN). This joint financial support is augmented by additional core funding to support network activities by the NI HSC R&DD. This will enable us to achieve our goals of promoting high quality cancer care in Northern Ireland by inclusion of patients on a geographically more equitable basis into cancer clinical trials, translational research and other well-organised cancer research studies.
The established strengths of NICTN, based on NICTC activity over the years lie in the following areas of clinical and translational research: haematological malignancy, GI, GU, gynaecological, breast and lung cancer, radiation and paediatric oncology.
There are other areas that NICTN wishes to strengthen and develop over the next five years, and which are also of high priority. These include:
- supportive and palliative care
- surgical trials
- imaging trials
- prevention and early diagnosis trials
- survivorship studies
NICTC will organise and co-ordinate their own and others' trials for both NICTC and NICTN staff in Belfast Health and Social Care Trust and also for NICTN staff in the other four Northern Irish HSC Trusts. The NICTN staff based outside BHSCT will deliver only a proportion of the overall trials portfolio (eg they will not perform early phase trials, paediatric trials or certain complex interventional trials). Their trials will also depend on the cancer services based in the units and the particular patient groups treated there.
For details of the NICTN Clinical Research Nurses, please click here.